Skip to content

OSCAR HEALTH INC CLASS A (OSCR) — insider trading

Financials · NYSE

OSCAR HEALTH INC CLASS A (OSCR) has 99 reported SEC Form 4 insider transactions in our data, including 45 open-market sales among the most recent 99 (latest 2026-09-18).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-09-18 WITTMAN VANESSA AMES Director Open-market sale 25,000 $32.24 $806.0K Form 4
2026-09-18 Kushner Joshua Director, Officer (Co-Founder and Vice Chairman), 10% owner Other acquisition or disposition (derivative) 75,520 — $0 Form 4
2026-09-18 Kushner Joshua Director, Officer (Co-Founder and Vice Chairman), 10% owner Other acquisition or disposition (derivative) 6,268,097 — $0 Form 4
2026-09-18 Kushner Joshua Director, Officer (Co-Founder and Vice Chairman), 10% owner Other acquisition or disposition (derivative) 164,218 — $0 Form 4
2026-09-18 Kushner Joshua Director, Officer (Co-Founder and Vice Chairman), 10% owner Other acquisition or disposition (derivative) 4,855,810 — $0 Form 4
2026-09-18 Kushner Joshua Director, Officer (Co-Founder and Vice Chairman), 10% owner Other acquisition or disposition (derivative) 1,323,589 — $0 Form 4
2026-09-18 Kushner Joshua Director, Officer (Co-Founder and Vice Chairman), 10% owner Other acquisition or disposition 164,218 — $0 Form 4
2026-09-18 Kushner Joshua Director, Officer (Co-Founder and Vice Chairman), 10% owner Other acquisition or disposition 4,855,810 — $0 Form 4
2026-09-18 Kushner Joshua Director, Officer (Co-Founder and Vice Chairman), 10% owner Other acquisition or disposition 1,323,589 — $0 Form 4
2026-09-18 Kushner Joshua Director, Officer (Co-Founder and Vice Chairman), 10% owner Other acquisition or disposition 164,218 — $0 Form 4
2026-09-18 Kushner Joshua Director, Officer (Co-Founder and Vice Chairman), 10% owner Other acquisition or disposition 4,855,810 — $0 Form 4
2026-09-18 Kushner Joshua Director, Officer (Co-Founder and Vice Chairman), 10% owner Other acquisition or disposition 1,323,589 — $0 Form 4
2026-09-18 Kushner Joshua Director, Officer (Co-Founder and Vice Chairman), 10% owner Other acquisition or disposition 75,520 — $0 Form 4
2026-09-18 Kushner Joshua Director, Officer (Co-Founder and Vice Chairman), 10% owner Other acquisition or disposition 6,268,097 — $0 Form 4
2026-09-18 Thrive Partners II GP, LLC; Thrive Capital Partners II, L.P.; Thrive Partners III GP, LLC; Thrive Capital Partners III, L.P.; Claremount TW, L.P.; Thrive Partners VII Growth GP, LLC; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Claremount VII Associates, L.P. Director, 10% owner Other acquisition or disposition (derivative) 75,520 — $0 Form 4
2026-09-18 Thrive Partners II GP, LLC; Thrive Capital Partners II, L.P.; Thrive Partners III GP, LLC; Thrive Capital Partners III, L.P.; Claremount TW, L.P.; Thrive Partners VII Growth GP, LLC; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Claremount VII Associates, L.P. Director, 10% owner Other acquisition or disposition (derivative) 6,268,097 — $0 Form 4
2026-09-18 Thrive Partners II GP, LLC; Thrive Capital Partners II, L.P.; Thrive Partners III GP, LLC; Thrive Capital Partners III, L.P.; Claremount TW, L.P.; Thrive Partners VII Growth GP, LLC; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Claremount VII Associates, L.P. Director, 10% owner Other acquisition or disposition (derivative) 164,218 — $0 Form 4
2026-09-18 Thrive Partners II GP, LLC; Thrive Capital Partners II, L.P.; Thrive Partners III GP, LLC; Thrive Capital Partners III, L.P.; Claremount TW, L.P.; Thrive Partners VII Growth GP, LLC; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Claremount VII Associates, L.P. Director, 10% owner Other acquisition or disposition (derivative) 4,855,810 — $0 Form 4
2026-09-18 Thrive Partners II GP, LLC; Thrive Capital Partners II, L.P.; Thrive Partners III GP, LLC; Thrive Capital Partners III, L.P.; Claremount TW, L.P.; Thrive Partners VII Growth GP, LLC; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Claremount VII Associates, L.P. Director, 10% owner Other acquisition or disposition (derivative) 1,323,589 — $0 Form 4
2026-09-18 Thrive Partners II GP, LLC; Thrive Capital Partners II, L.P.; Thrive Partners III GP, LLC; Thrive Capital Partners III, L.P.; Claremount TW, L.P.; Thrive Partners VII Growth GP, LLC; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Claremount VII Associates, L.P. Director, 10% owner Other acquisition or disposition 164,218 — $0 Form 4
2026-09-18 Thrive Partners II GP, LLC; Thrive Capital Partners II, L.P.; Thrive Partners III GP, LLC; Thrive Capital Partners III, L.P.; Claremount TW, L.P.; Thrive Partners VII Growth GP, LLC; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Claremount VII Associates, L.P. Director, 10% owner Other acquisition or disposition 4,855,810 — $0 Form 4
2026-09-18 Thrive Partners II GP, LLC; Thrive Capital Partners II, L.P.; Thrive Partners III GP, LLC; Thrive Capital Partners III, L.P.; Claremount TW, L.P.; Thrive Partners VII Growth GP, LLC; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Claremount VII Associates, L.P. Director, 10% owner Other acquisition or disposition 1,323,589 — $0 Form 4
2026-09-18 Thrive Partners II GP, LLC; Thrive Capital Partners II, L.P.; Thrive Partners III GP, LLC; Thrive Capital Partners III, L.P.; Claremount TW, L.P.; Thrive Partners VII Growth GP, LLC; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Claremount VII Associates, L.P. Director, 10% owner Other acquisition or disposition 164,218 — $0 Form 4
2026-09-18 Thrive Partners II GP, LLC; Thrive Capital Partners II, L.P.; Thrive Partners III GP, LLC; Thrive Capital Partners III, L.P.; Claremount TW, L.P.; Thrive Partners VII Growth GP, LLC; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Claremount VII Associates, L.P. Director, 10% owner Other acquisition or disposition 4,855,810 — $0 Form 4
2026-09-18 Thrive Partners II GP, LLC; Thrive Capital Partners II, L.P.; Thrive Partners III GP, LLC; Thrive Capital Partners III, L.P.; Claremount TW, L.P.; Thrive Partners VII Growth GP, LLC; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Claremount VII Associates, L.P. Director, 10% owner Other acquisition or disposition 1,323,589 — $0 Form 4
2026-09-18 Thrive Partners II GP, LLC; Thrive Capital Partners II, L.P.; Thrive Partners III GP, LLC; Thrive Capital Partners III, L.P.; Claremount TW, L.P.; Thrive Partners VII Growth GP, LLC; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Claremount VII Associates, L.P. Director, 10% owner Other acquisition or disposition 75,520 — $0 Form 4
2026-09-18 Thrive Partners II GP, LLC; Thrive Capital Partners II, L.P.; Thrive Partners III GP, LLC; Thrive Capital Partners III, L.P.; Claremount TW, L.P.; Thrive Partners VII Growth GP, LLC; Thrive Capital Partners VII Growth, L.P.; Thrive Partners VII GP, LLC; Claremount VII Associates, L.P. Director, 10% owner Other acquisition or disposition 6,268,097 — $0 Form 4
2026-09-03 Schlosser Mario Director Open-market sale 31,422 $31.45 $988.2K Form 4
2026-09-03 McAnaney Adam Officer (Chief Legal Officer) Open-market sale 9,092 $31.45 $285.9K Form 4
2026-09-03 Liang Janet Officer (President, Oscar Insurance) Open-market sale 10,360 $31.45 $325.8K Form 4
2026-09-03 Blackley Richard Scott Officer (Chief Financial Officer) Open-market sale 28,869 $31.45 $907.9K Form 4
2026-09-03 Baltrus Victoria Officer (Chief Accounting Officer) Open-market sale 958 $31.45 $30.1K Form 4
2026-08-28 Schlosser Mario Director Conversion of derivative (derivative) 150,000 — $0 Form 4
2026-08-28 Schlosser Mario Director Option exercise / conversion (derivative) 150,000 $9.75 $1.46M Form 4
2026-08-28 Schlosser Mario Director Option exercise / conversion (derivative) 150,000 — $0 Form 4
2026-08-28 Schlosser Mario Director Open-market sale 150,000 $30.79 $4.62M Form 4
2026-08-28 Schlosser Mario Director Conversion of derivative 150,000 — — Form 4
2026-08-27 Schlosser Mario Director Conversion of derivative (derivative) 600,000 — $0 Form 4
2026-08-27 Schlosser Mario Director Option exercise / conversion (derivative) 600,000 $9.75 $5.85M Form 4
2026-08-27 Schlosser Mario Director Option exercise / conversion (derivative) 600,000 — $0 Form 4
2026-08-27 Schlosser Mario Director Open-market sale 600,000 $30.34 $18.20M Form 4
2026-08-27 Schlosser Mario Director Conversion of derivative 600,000 — — Form 4
2026-08-18 Blackley Richard Scott Officer (Chief Financial Officer) Open-market sale 18,750 $31.74 $595.1K Form 4
2026-07-09 Plouffe David Director Grant / award / vesting (derivative) 681 $31.20 $21.2K Form 4
2026-07-09 Sankaran Sid Director Grant / award / vesting (derivative) 858 $31.20 $26.8K Form 4
2026-07-09 Gassen William Director Grant / award / vesting (derivative) 684 $31.20 $21.3K Form 4
2026-07-01 Schlosser Mario Director Conversion of derivative (derivative) 47,500 — $0 Form 4
2026-07-01 Schlosser Mario Director Open-market sale 30,228 $31.65 $956.7K Form 4
2026-07-01 Schlosser Mario Director Open-market sale 13,672 $30.80 $421.1K Form 4
2026-07-01 Schlosser Mario Director Open-market sale 3,600 $29.50 $106.2K Form 4
2026-07-01 Schlosser Mario Director Conversion of derivative 47,500 — — Form 4
2026-06-30 Bertolini Mark T Director, Officer (Chief Executive Officer) Open-market sale 135,590 $28.97 $3.93M Form 4
2026-06-30 Bertolini Mark T Director, Officer (Chief Executive Officer) Open-market sale 488,654 $28.35 $13.85M Form 4
2026-06-29 Bertolini Mark T Director, Officer (Chief Executive Officer) Open-market sale 58,926 $30.08 $1.77M Form 4
2026-06-29 Bertolini Mark T Director, Officer (Chief Executive Officer) Open-market sale 555,826 $29.17 $16.21M Form 4
2026-06-26 Bertolini Mark T Director, Officer (Chief Executive Officer) Open-market sale 149,795 $29.79 $4.46M Form 4
2026-06-26 Bertolini Mark T Director, Officer (Chief Executive Officer) Open-market sale 441,373 $29.11 $12.85M Form 4
2026-06-25 Bertolini Mark T Director, Officer (Chief Executive Officer) Open-market sale 17,200 $29.08 $500.2K Form 4
2026-06-25 Bertolini Mark T Director, Officer (Chief Executive Officer) Open-market sale 597,942 $28.60 $17.10M Form 4
2026-06-23 Schlosser Mario Director Conversion of derivative (derivative) 47,500 — $0 Form 4
2026-06-23 Schlosser Mario Director Conversion of derivative (derivative) 50,000 — $0 Form 4
2026-06-23 Schlosser Mario Director Conversion of derivative (derivative) 50,000 — $0 Form 4
2026-06-23 Schlosser Mario Director Conversion of derivative (derivative) 880,000 — $0 Form 4
2026-06-23 Schlosser Mario Director Option exercise / conversion (derivative) 660,000 $9.75 $6.43M Form 4
2026-06-23 Schlosser Mario Director Option exercise / conversion (derivative) 660,000 — $0 Form 4
2026-06-23 Schlosser Mario Director Open-market sale 97 $30.09 $2.9K Form 4
2026-06-23 Schlosser Mario Director Open-market sale 31,912 $29.58 $944.0K Form 4
2026-06-23 Schlosser Mario Director Open-market sale 15,491 $28.95 $448.5K Form 4
2026-06-23 Schlosser Mario Director Conversion of derivative 47,500 — — Form 4
2026-06-23 Schlosser Mario Director Open-market sale 102 $30.09 $3.1K Form 4
2026-06-23 Schlosser Mario Director Open-market sale 33,592 $29.58 $993.7K Form 4
2026-06-23 Schlosser Mario Director Open-market sale 16,306 $28.95 $472.1K Form 4
2026-06-23 Schlosser Mario Director Conversion of derivative 50,000 — — Form 4
2026-06-23 Schlosser Mario Director Open-market sale 102 $30.09 $3.1K Form 4
2026-06-23 Schlosser Mario Director Open-market sale 33,591 $29.58 $993.6K Form 4
2026-06-23 Schlosser Mario Director Open-market sale 16,307 $28.95 $472.1K Form 4
2026-06-23 Schlosser Mario Director Conversion of derivative 50,000 — — Form 4
2026-06-23 Schlosser Mario Director Open-market sale 1,799 $30.09 $54.1K Form 4
2026-06-23 Schlosser Mario Director Open-market sale 591,213 $29.58 $17.49M Form 4
2026-06-23 Schlosser Mario Director Open-market sale 286,988 $28.95 $8.31M Form 4
2026-06-23 Schlosser Mario Director Conversion of derivative 880,000 — — Form 4
2026-06-04 WITTMAN VANESSA AMES Director Grant / award / vesting 8,475 — $0 Form 4
2026-06-04 Gassen William Director Grant / award / vesting 8,475 — $0 Form 4
2026-06-04 Sankaran Sid Director Grant / award / vesting 8,475 — $0 Form 4
2026-06-04 Plouffe David Director Grant / award / vesting 8,475 — $0 Form 4
2026-06-04 Lang Laura W Director Grant / award / vesting 8,475 — $0 Form 4
2026-06-02 Blackley Richard Scott Officer (Chief Financial Officer) Open-market sale 8,977 $22.45 $201.5K Form 4
2026-06-02 Blackley Richard Scott Officer (Chief Financial Officer) Open-market sale 22,706 $21.74 $493.6K Form 4
2026-06-02 Liang Janet Officer (President, Oscar Insurance) Open-market sale 3,535 $22.45 $79.4K Form 4
2026-06-02 Liang Janet Officer (President, Oscar Insurance) Open-market sale 8,940 $21.74 $194.4K Form 4
2026-06-02 McAnaney Adam Officer (Chief Legal Officer) Open-market sale 2,794 $22.45 $62.7K Form 4
2026-06-02 McAnaney Adam Officer (Chief Legal Officer) Open-market sale 7,065 $21.74 $153.6K Form 4
2026-06-02 Schlosser Mario Director Open-market sale 9,668 $22.45 $217.0K Form 4
2026-06-02 Schlosser Mario Director Open-market sale 24,452 $21.74 $531.6K Form 4
2026-06-02 Baltrus Victoria Officer (Chief Accounting Officer) Open-market sale 432 $22.45 $9.7K Form 4
2026-06-02 Baltrus Victoria Officer (Chief Accounting Officer) Open-market sale 1,091 $21.74 $23.7K Form 4
2026-05-18 Blackley Richard Scott Officer (Chief Financial Officer) Open-market sale 110,000 $25.03 $2.75M Form 4
2026-05-14 Blackley Richard Scott Officer (Chief Financial Officer) Open-market sale 8,741 $23.79 $207.9K Form 4
2026-05-14 Blackley Richard Scott Officer (Chief Financial Officer) Open-market sale 91,259 $23.10 $2.11M Form 4

Ask the chat about OSCR's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: OSCAR HEALTH INC CLASS A (OSCR).

Last updated 2026-09-18 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.